Market Insights
Professional Development Through Knowledge Sharing
Hospital @ Home
The Transformation of Virtual Care
Pharma Contract Services Industry Outlook 2023
Highlights, Trends, Opportunities & Outlook
2023 & 2024 Life Science Market Outlook
Highlights, Trends, Opportunities & Outlook
2023 Artificial Intelligence in Life Sciences Market Insight
Highlights, Trends, Opportunities & Outlook
2023 Life Sciences & Healthcare Consulting Market Insight
Highlights, Trends, Opportunities & Outlook
Strategic Survival During A Downturn
How The HealthTech Industry Is Entering A (Probable) Recession, And Ways Management Teams Can Navigate Newly Unchartered Waters
2022 Pharma Contract Services Industry Outlook
Outcome Capital shares their analysis and insights on pivotal trends and opportunities within the Pharma Contract Services sector.
2022 Digital Health Sector: Highlights, Trends & Opportunities
Outcome Capital shares their analysis and insights on pivotal trends and opportunities within the Digital Health sector.
2022 Medical Device Sector: Highlights, Trends & Opportunities
Outcome Capital shares their views, insights and data on key strategic trends and dynamics in the Medical Device sector.
2022 Biopharma Industry Outlook: Highlights, Trends & Opportunities
Outcome Capital shares their views, insights and data on key strategic trends and dynamics in the biopharma sector. This segment is poised for significant growth, scientific advancement and consolidation.
2022 Life Science Consulting Sector: Market Trends, Dynamics & Opportunities
Outcome Capital shares their views, insights and data on key strategic trends and dynamics in the life science consulting sector. This vibrant segment is poised for significant growth and consolidation.
Digital Health Sector: Trends and Opportunities
Outcome Capital shares their views, insights and data on key strategic and financial trends within the Virtual Care, Population Health and Tech-Enabled Payor segments. These vibrant segment niches of the broader Digital Health industry are poised for significant investment and consolidation.
Biology & Digital Technology Merger Gives Rise to Spatial Biology
As a highly specialized life science advisory and investment banking firm, Outcome Capital looks to identify emerging trends that effect how researchers and clinicians understand, diagnose, and treat disease.
Shining the Light on Diagnostic Shortcomings During the COVID Pandemic Reveals a Stronger Path for the Future
Outcome Capital sat down and spoke with Dr. Cathy Petti to get her perspective on the shortcomings of COVID diagnosis and how to carve out a stronger path for the future.
Grabbing Hold of the COVID-19 Pandemic as a Diagnostic Company
Outcome Capital sat down and spoke with Chuck Morrison to get his thoughts on the effects of the current COVID-19 pandemic on diagnostic transactional activity in 2020 and how best to weather the economic environment.
In Vitro Diagnostic Market Insight: Continued Growth and Consolidation
The In Vitro Diagnostic market values established companies with regulatory approval and market traction. This is demonstrated by premiums paid for acquisitions of companies that offer the opportunity to quickly capture market share and IPOs of companies with significant revenues.
Update in Immuno-Oncology: Multiplicity of Drug In-Licensing Opportunities to Expand Your Pipeline
This market update captures assets currently in development and recent partnering/in-licensing transactions which can catalyze development and improve valuation for companies.
Ophthalmology Market: Opportunity for Growth Remains
The ophthalmology market values innovation approaches, demonstrated by premiums paid for acquisition of first-in-class therapies and public market support of ophthalmology gene therapy companies.
Cell-based Therapies: A Maturing Market Poised for Growth
The cell-based therapy market will grow significantly, supported by recent clarity in the FDA pathway, improved clinical outcomes as well as market entry by big pharma.
Contact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2024. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Business Continuity Plan | Privacy Policy | Regulation Best Interest
